Table 15:
Scenario Analysis Result, Treatment Incorporating Subsequent Lines of Psoriasis Treatments
| Strategy | Average Total Costs (95% CrI) | Incremental Costa (95% CrI) | Average Total QALYs (95% CrI) | Incremental QALYb (95% CrI) | ICER ($/QALY) |
|---|---|---|---|---|---|
| Outpatient clinic NB-UVB | $17,621 (12,276–24,344) | – | 7.18 (6.83–7.51) | – | – |
| Home NB-UVB | $20,019 (16,216–24,839) | $2,398 (−3,780 to 8,212) | 7.45 (7.11–7.79) | 0.27 (−0.21 to 0.75) | 8,877 |
Abbreviations: CrI, credible interval; ICER, incremental cost-effectiveness ratio; NB-UVB, narrowband ultraviolet B phototherapy; QALY, quality-adjusted life year.
a
Incremental cost = average cost (strategy B) - average cost (strategy A).
b
Incremental effect = average effect (strategy B) - average effect (strategy A).